Andy Slee

Company: Protagenic Therapeutics

Job title: Chief Scientific Officer

Seminars:

Novel BBB-Surpassing Peptide Structure for Unlocking New Treatment Avenues 2:00 pm

Developing peptide-based drugs for the treatment of affective disorders Peptides derived from natural genomic sequences with low toxicity and the ability to surpass the blood-brain-barrier Exploring PTIs lead compound, PT00114, which is currently in clinical trialsRead more

day: Conference Day 1